Clinical Trial Update: Patient Preference for Subcutaneous vs. Intravenous Immune Therapy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on patient preference for subcutaneous versus intravenous immune therapy; the study is currently recruiting across multiple cancer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Colorectal Cancer
• Esophageal Cancer
• Hepatocellular Carcinoma
• Melanoma
• Non-small Cell Lung Cancer
• Renal Cell Carcinoma
• Ulcerative Colitis

Snippet

Sponsor: Diwakar Davar | Conditions: Renal Cell Carcinoma, Non Small Cell Lung Cancer | Phase 2 | Status: RECRUITING